112 results
Page 3 of 6
6-K
EX-99.1
ofiob5
14 Mar 22
Current report (foreign)
10:05am
6-K
EX-99.1
94qhf8ak2
22 Dec 21
Alvelestat reported safe and well-tolerated in patients with COVID-19
7:45am
6-K
EX-99.1
suien796iynm0ji
30 Nov 21
Mereo BioPharma Reports Interim Data from ACTIVATE Phase 1b/2 Open Label Study of
7:51am
6-K
EX-99.2
p351eh03u7sw3
2 Nov 21
Current report (foreign)
4:16pm
6-K
EX-99.1
9w1zmqq v7bxuh
1 Oct 21
Current report (foreign)
4:43pm
6-K
EX-99.1
r5om6nbzbn6uyrz1ow5f
2 Jun 21
Current report (foreign)
8:24am
6-K
EX-99.1
i01gvt9o9
16 Apr 21
Current report (foreign)
4:10pm
424B5
jhk3bvy yxla
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
es5p25qy6fr6c6bj3aj5
9 Feb 21
Prospectus supplement for primary offering
5:24pm
6-K
EX-99.1
b9r359erozz2ckd8
17 Dec 20
Mereo BioPharma and Ultragenyx Announce Collaboration and License
5:16pm
424B5
4njtpieib0mri 3dfyp0
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
n0y2jbwbnx73qm85e
6 Oct 20
Shelf registration (foreign)
4:25pm
6-K
EX-99.2
kliq9073bzbx3d0 fnk
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
aml4t
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
cckcbtnoq91sr
25 Aug 20
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
11:14am
6-K
j0akg28aanyg3rmy676
16 Jun 20
Current report (foreign)
4:13pm